## TMUS: T-Mobile US, Inc. - XLC: Communication Services

### Executive Summary

VALUE thesis: PEG 0.80 indicates fundamental undervaluation. Quality metrics strong (ROE 19%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.6% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($185.97)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. T-Mobile US (TMUS) Stock: Wall Street Stays Bullish as 2025 Selloff Deepens â€“ Latest News, Ratings and Forecasts (December 10, 2025)**
- Source: ts2.tech | 20251210T190856 | Somewhat-Bullish | Relevance: 99%
- T-Mobile US (TMUS) is experiencing a volatile end to 2025, with its share price near 52-week lows despite strong fundamentals like record customer growth and raised guidance. Wall Street analysts remain largely bullish, with consensus price targets suggesting 25-40% upside, attributing the disconnect to sector headwinds and temporary market sentiment. The article details updated analyst ratings, insider activity, and T-Mobile's robust Q3 2025 performance, alongside its strategic growth drivers including 5G expansion, the UScellular acquisition, and AI integration.

**2. T-Mobile US stock hits 52-week low at $199.26**
- Source: Investing.com | 20251209T160842 | Neutral | Relevance: 99%
- T-Mobile US Inc.'s stock has reached a new 52-week low of $199.26, a significant drop from its 52-week high of $276.49 and a 14.39% decline over the past year. Despite this, InvestingPro analysis suggests the stock is undervalued, exhibiting fundamental strength with revenue growth and a modest dividend yield. The company recently declared a quarterly dividend and announced a new COO, while analysts have offered mixed but largely positive ratings.

**3. T-Mobile US (TMUS) Analyst Rating: Argus Research Lowers Price Target | TMUS Stock News**
- Source: GuruFocus | 20251209T143640 | Neutral | Relevance: 99%
- Argus Research has reiterated its 'Buy' rating for T-Mobile US (TMUS) but has lowered the price target from $275 to $245, a 10.91% decrease. This adjustment reflects recent analyst actions, which also include other firms upgrading, downgrading, or maintaining ratings with revised price targets. Despite the lowered price target, the average analyst target price for TMUS remains $274.12, suggesting a potential upside of 34.09% from its current price, with a consensus "Outperform" status from brokerage firms.

**4. T-Mobile US stock hits 52-week low at $199.26 By Investing.com**
- Source: Investing.com Nigeria | 20251209T161241 | Neutral | Relevance: 99%
- T-Mobile US (NASDAQ: TMUS) stock has fallen to a new 52-week low of $199.26, reflecting a 14.39% decline over the past year, despite being considered undervalued by InvestingPro. The company maintains a strong market capitalization and P/E ratio, with management actively buying back shares and a 2.0% dividend yield. Recent developments include a declared quarterly cash dividend, a new Chief Operating Officer, and various analyst upgrades and reiterated Buy ratings, reflecting ongoing efforts to enhance market position and financial performance.

**5. T-Mobile US Unveils $14.6 Billion Shareholder Return Plan**
- Source: TipRanks | 20251211T215450 | Bullish | Relevance: 98%
- T-Mobile US (TMUS) announced a new shareholder return program of up to $14.6 billion, including share repurchases and cash dividends, extending through December 31, 2026. This initiative follows a previous $14.0 billion program and aims to boost shareholder value, with its execution being subject to market conditions and company performance. An analyst has rated TMUS stock as a Buy with a $300.00 price target, while TipRanks' AI Analyst, Spark, rates it as "Outperform," highlighting strong financial performance but noting risks from bearish technical indicators and high leverage.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Morgan Stanley | $260 | $280 | -7% |
| 2025-12-09 | Argus Research | $245 | $275 | -11% |
| 2025-12-02 | Keybanc | $0 | $0 | 0% |
| 2025-11-21 | Oppenheimer | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Morgan Stanley | main | Overweight |
| 2025-12-09 | Argus Research | main | Buy |
| 2025-12-02 | Keybanc | up | Sector Weight |
| 2025-11-21 | Oppenheimer | down | Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($1.98M) |
| Sells | 40 ($146.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 21.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Softbank Group Corpo: 4.0% (-29.3%)
- Vanguard Group Inc: 3.8% (+1.5%)
- Blackrock Inc.: 3.5% (+5.3%)
- State Street Corpora: 2.2% (+4.7%)
- Price (T.Rowe) Assoc: 1.9% (+17.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.6% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $146M sold (40 transactions in 90 days).
3. Long-term trend broken: trading 18.0% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Balance sheet: $4.8B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($146.2M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $219.8B |
| Beta | 0.44 |
| 52W Range | $194.66 - $276.49 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 16.7 |
| Current P/E | 19.4 |
| YoY Growth | 15.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -2.5% to -8.1% (-5.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 12.1pp (needs >4.0% for momentum thesis). AM_20 at -6.0% indicates price below own 20MA trend. Underperforming sector by 8.3pp, stock-specific weakness. Below SMA200 (0.82x), long-term trend not supportive. MACD histogram bearish (-0.89), momentum weakening. RSI oversold at 28, potential bounce setup. Elevated volume (1.3x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -8.10% (CS: 3) | Weak |
| RSI_14 | 28.5 | Oversold |
| MACD Histogram | -0.89 | Bearish |
| vs SMA20 | 0.939x | Below |
| vs SMA50 | 0.909x | Below |
| vs SMA200 | 0.820x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $195.33
- **Stop Loss:** $185.97 (4.8% risk)
- **Target:** $214.05 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 122
- **Position Value:** $23,830.26
- **Portfolio %:** 23.83%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-04 (Est: $2.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.40 | $2.41 | +0.4% |
| 2025Q2 | $2.67 | $2.84 | +6.3% |
| 2025Q1 | $2.47 | $2.58 | +4.5% |
| 2024Q4 | $2.28 | $2.57 | +12.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*